PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9102228-11	1997	Inhibition of N-linked glycosylation with tunicamycin resulted in decreased HA binding of cells bearing an active CD44 receptor.	Tunicamycin	42-53	CD44 molecule (Indian blood group)	Homo sapiens	114-118	
9111868-15	1997	In many, but not in all cases, CD44 does not bind HA unless it is stimulated by phorbol esters, activated by agonistic anti-CD44 antibody, or deglycosylated (e.g., by tunicamycin).	Tunicamycin	167-178	CD44 molecule (Indian blood group)	Homo sapiens	31-35	
8601595-3	1996	Our results show that treatment of a panel of human cell lines which constitutively express CD44 with the inhibitor of N-linked glycosylation tunicamycin results in the loss of attachment of these cells to hyaluronate-coated substrate.	Tunicamycin	142-153	CD44 molecule (Indian blood group)	Homo sapiens	92-96	
20970123-2	2011	Inhibition of CD44 N- and O-linked glycosylation by using tunicamycin and/or B-GalNAc statistically significantly inhibited endometrial cell attachment to peritoneal mesothelial cells, suggesting a role in establishment of early endometriotic lesions.	Tunicamycin	58-69	CD44 molecule (Indian blood group)	Homo sapiens	14-18	
10714394-8	2000	Similarly, under suboptimal conditions, a synergistic effect was obtained with tunicamycin and PMA: each one alone was ineffective but in combination they induced the acquisition of HA binding by the lymphoma cells, while their CD44 expression was not enhanced.	Tunicamycin	79-90	CD44 molecule (Indian blood group)	Homo sapiens	228-232	
29377347-0	2018	Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.	Tunicamycin	0-11	CD44 molecule (Indian blood group)	Homo sapiens	105-109	
27350212-0	2016	Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.	Tunicamycin	0-11	CD44 molecule (Indian blood group)	Homo sapiens	96-100	
27350212-4	2016	In this study we show effect of tunicamycin on subpopulation and invasion of CD44+/CD24- MCF7 breast cancer stem cells.	Tunicamycin	32-43	CD44 molecule (Indian blood group)	Homo sapiens	77-81	
27350212-5	2016	CD44+/CD24- cells were isolated from MCF7 cell line by fluorescence activated cell sorting (FACS) and treated with tunicamycin.	Tunicamycin	115-126	CD44 molecule (Indian blood group)	Homo sapiens	0-4	
27350212-9	2016	Increased level of spliced XBP-1, ATF6 nuclear translocation and CHOP protein expression were detected in CD44+/CD24- and original MCF7 cells treated with tunicamycin.	Tunicamycin	155-166	CD44 molecule (Indian blood group)	Homo sapiens	106-110	
27350212-10	2016	Also, a significant decline in CD44+/CD24- cell subpopulation was determined in the cells treated with tunicamycin.	Tunicamycin	103-114	CD44 molecule (Indian blood group)	Homo sapiens	31-35	
27350212-11	2016	The results also showed inhibited invasion, increased cell death, suppressed proliferation and reduced migration in the CD44+/CD24- and CD44+/CD24- rich MCF7 cell culture, under effect of tunicamycin.	Tunicamycin	188-199	CD44 molecule (Indian blood group)	Homo sapiens	120-124	
27350212-11	2016	The results also showed inhibited invasion, increased cell death, suppressed proliferation and reduced migration in the CD44+/CD24- and CD44+/CD24- rich MCF7 cell culture, under effect of tunicamycin.	Tunicamycin	188-199	CD44 molecule (Indian blood group)	Homo sapiens	136-140	
27350212-12	2016	Our results indicate that CD44+/CD24- phenotype MCF7 cells are susceptible to tunicamycin.	Tunicamycin	78-89	CD44 molecule (Indian blood group)	Homo sapiens	26-30	
27350212-13	2016	The results showed that tunicamycin-induced ER stress suppresses CD44+/CD24- phenotype cell subpopulation and in vitro invasion and accelerates tumorosphore formation.	Tunicamycin	24-35	CD44 molecule (Indian blood group)	Homo sapiens	65-69	
27350212-14	2016	These results suggest that tunicamycin-induced ER stress inhibits CD44+/CD24- phenotype MCF7 breast cancer stem cells.	Tunicamycin	27-38	CD44 molecule (Indian blood group)	Homo sapiens	66-70